US Stock MarketDetailed Quotes

ITCI Intra-Cellular Therapies

Watchlist
  • 78.340
  • -0.340-0.43%
Close Oct 18 16:00 ET
  • 78.340
  • 0.0000.00%
Post 20:01 ET
8.28BMarket Cap-91093P/E (TTM)

Intra-Cellular Therapies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Intra-Cellular Therapies Q3 2024 Estimates Date

Currency：USDOct 30, 2024

Estimate YoY
Revenue
172.35M
+36.60%
EPS
-0.21
+16.37%
Analyst Rating
Strong Buy

Oct 20, 2024

Intra-Cellular Therapies Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 187.855M--
Oct 30, 20242024/Q3-- / 172.353M--
Aug 7, 20242024/Q2161.388M / 157.884M--
May 7, 20242024/Q1144.866M / 141.444M--
Feb 22, 20242023/Q4132.099M / 135.668M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 187.855M--
Oct 30, 20242024/Q3-- / 172.353M--
Aug 7, 20242024/Q2161.388M / 157.884M--
May 7, 20242024/Q1144.866M / 141.444M--
Feb 22, 20242023/Q4132.099M / 135.668M--

Unlock Free Earnings Estimates

Intra-Cellular Therapies Earnings Reports

  • Intra-Cellular Therapies | 10-Q: Q2 2024 Earnings Report

    Aug 7 07:56 ET

  • Intra-Cellular Therapies | 10-Q: Q1 2024 Earnings Report

    May 7 07:44 ET

  • Intra-Cellular Therapies | 10-K: FY2023 Annual Report

    Feb 22 07:46 ET

  • Intra-Cellular Therapies | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 08:01 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 20, 2024

    Strong Buy

    • Buy

      92.31%

    • Hold

      7.69%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data